Skip to main content
Equibles
ITGR logo

ITGR · Integer Holdings Corp · Metrics

Track ITGR — free

Use ITGR with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research ITGR.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$126.70 -0.05 (-0.04%) At close · Oct 20
S&P 600 member Russell 2000 member Rebalance outlook locked
Market Cap
$4.31B
Shares
33.99M
Volume · Oct 20 904.75K Avg daily vol (3M) 1.06M

ITGR metrics

111 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$126.70
Market cap
$4.31B

Price action

20 metrics
Price change (1W)
+0.1%
Price change (30D)
+0.3%
Price change (3M)
+31.6%
Price change (6M)
+48.0%
Price change (YTD)
+61.5%
Price change (1Y)
+18.0%
Trailing year
Price change (5Y)
+39.4%
52-week high
$126.75
52-week low
$63.32
Change from 52-week high
0.0%
Change from 52-week low
+100.1%
Annualized volatility
46.2%
Annualized volatility (3M)
40.1%
Beta
0.6
RSI (14D)
72.4
Price vs SMA 50
+0.6%
Price vs SMA 200
+27.9%
Avg volume (3M)
1.06M
Relative volume
0.9
Average dollar volume
$131.92M

Company

3 metrics
Sector
Healthcare
Industry
Medical Devices
Shares outstanding
33.99M

Valuation

12 metrics
P / E (TTM)
34.4
Trailing earnings · reciprocal yield 2.9%
PEG ratio
—
EV / revenue
3.0×
reciprocal yield 33.4%
EV / EBITDA
17.4×
reciprocal yield 5.7%
EV / EBIT
30.9×
reciprocal yield 3.2%
P / sales
2.3×
reciprocal yield 42.8%
P / book
2.5
reciprocal yield 39.9%
FCF yield
2.6%
TTM · current market cap
Buyback yield
2.3%
P / FCF
38.5
reciprocal yield 2.6%
P / operating cash flow
21.0
reciprocal yield 4.8%
Earnings yield
3.0%

Historical valuation

8 metrics
P / E historical average (3Y)
37.2×
reciprocal yield 2.7%
P / E historical average (5Y)
36.1×
reciprocal yield 2.8%
EV / revenue historical average (3Y)
2.7×
reciprocal yield 36.8%
EV / revenue historical average (5Y)
2.7×
reciprocal yield 37.0%
EV / EBIT historical average (3Y)
24.1×
reciprocal yield 4.1%
EV / EBIT historical average (5Y)
25.3×
reciprocal yield 4.0%
EV / EBITDA historical average (3Y)
15.3×
reciprocal yield 6.6%
EV / EBITDA historical average (5Y)
15.7×
reciprocal yield 6.4%

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
2.3%
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-06

Profitability

9 metrics
Gross margin
25.7%
Operating margin
9.7%
Trailing 12 months
Net margin
7.0%
Gross profit (TTM)
$473.45M
Operating profit (TTM)
$178.77M
Net income (TTM)
$128.40M
Trailing 12 months
Diluted EPS (TTM)
$3.68
FCF margin
6.1%
Effective tax rate
5.9%

Per share

11 metrics
Revenue per diluted share (TTM)
$52.26
Gross profit per diluted share (TTM)
$13.41
Operating profit per diluted share (TTM)
$5.03
EBITDA per diluted share (TTM)
$8.95
Net income per diluted share (TTM)
$3.60
Operating cash flow per diluted share (TTM)
$5.81
Free cash flow per diluted share (TTM)
$3.16
Capital expenditures per diluted share (TTM)
$2.65
R&D per diluted share (TTM)
$1.38
Stock compensation per diluted share (TTM)
$0.65
Book value per share
$50.85

Growth

11 metrics
Revenue growth YoY
-2.6%
Year over year
Net income growth YoY
-36.2%
Revenue (TTM)
$1.84B
Trailing 12 months
EPS growth YoY
-33.7%
Shares change YoY
-4.4%
Year over year · fewer shares
Revenue CAGR (3Y)
+11.7%
Revenue CAGR (5Y)
+11.5%
EPS CAGR (3Y)
+13.2%
EPS CAGR (5Y)
+4.4%
FCF CAGR (3Y)
+36.1%
FCF CAGR (5Y)
-4.8%

Quality

14 metrics
Return on equity
7.5%
Return on assets
3.8%
Debt / equity
0.7
Current ratio
3.7
EBITDA (TTM)
$316.87M
Free cash flow (TTM)
$111.98M
Quick ratio
2.4
Interest coverage
4.6
Net debt / EBITDA
3.8
Return on invested capital
5.7%
Trailing 12 months
Net cash
−$1.22B
Latest balance sheet
Cash & equivalents
$21.38M
Total assets
$3.42B
Total debt
$1.24B

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$205.44M
Capital expenditures (TTM)
$93.46M
R&D (TTM)
$48.58M
SG&A (TTM)
$224.07M
Stock compensation (TTM)
$22.73M
R&D / revenue
2.6%
Stock compensation / revenue
1.2%

Ownership (13F)

9 metrics
13F filers
334
13F filer change QoQ
+6
Institutional ownership
122.5%
Conviction holders (share of 13F filers)
1.5%
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
—
Active holders' share change QoQ
+5.5%
Holder tenure
14.4
Price vs estimated holder cost
+7.9%

Ownership (registered funds)

1 metrics
Index-fund ownership
29.1%

Short interest

3 metrics
Short interest
9.2%
Latest settlement · 3.5 days to cover
Days to cover
3.5d
Short-squeeze score
65 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$5.17M
Insider-sentiment score
18 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 1114483 CUSIP 45826H109 13F (30d) 45 filings 39 filers Visit website Investor relations